- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/50 - Nitrogen atoms
Patent holdings for IPC class C07D 207/50
Total number of patents in this class: 78
10-year publication summary
|
5
|
6
|
9
|
9
|
6
|
5
|
6
|
3
|
5
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Siga Technologies, Inc. | 84 |
5 |
| Topadur Pharma AG | 22 |
5 |
| Eth Zurich | 1283 |
4 |
| Novartis Pharmaceuticals Corporation | 51 |
3 |
| Ensysce Biosciences, Inc. | 20 |
3 |
| The Lubrizol Corporation | 1288 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 584 |
3 |
| Ono Pharmaceutical Co., Ltd. | 433 |
3 |
| The University of North Carolina at Chapel Hill | 2046 |
3 |
| Orion Ophthalmology LLC | 9 |
3 |
| Bayer HealthCare LLC | 1354 |
2 |
| The Cleveland Clinic Foundation | 1572 |
2 |
| Emory University | 1621 |
2 |
| Paratek Pharmaceuticals, Inc. | 111 |
2 |
| Zealand Pharma A/S | 259 |
2 |
| Novartis AG | 10741 |
1 |
| Bristol-myers Squibb Company | 4881 |
1 |
| F. Hoffmann-La Roche AG | 7945 |
1 |
| Syngenta Participations AG | 1904 |
1 |
| Glaxosmithkline Intellectual Property Development Limited | 763 |
1 |
| Other owners | 28 |